menu
    • menu

    Company profile for Novome Biotechnologies

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    Smithfield BioScience transforms bioproducts into trusted, life-saving therapies through safe, reliable U.S.-based manufacturing.

    Virtual Booth

    Contact Supplier

    Quotient Sciences- Molecule to Cure. Fast.

    Virtual Booth

    Contact Supplier

    SWATI - Transforming science into solutions with 60+ years of expertise, global accreditations, and pioneering biotech innovation.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    REF. STANDARDS & IMPURITIES

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Novome Biotechnologies is engineering bacteria from the human gut to treat diseases. Based on pioneering technology developed at Stanford University, we bring together experts in the fields of synthetic biology and the microbiome to build novel cell-based therapies.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Novome BiotechnologiesUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    279 E Grand Ave, Suite 420 South San Francisco, CA 94080
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://novomebio.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/novome-biotechnologies-inc./
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    DDL Conference

    Not Confirmed

    envelop Contact Supplier

    DDL Conference

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Colorcon Ventures Invests in Novome Biotechnologies
    Colorcon Ventures Invests in Novome Biotechnologies

    15 Sep 2022

    // PRNEWSWIRE

    https://www.prnewswire.com/news-releases/colorcon-ventures-invests-in-novome-biotechnologies-an-engineered-microbial-therapy-company-301625189.html

    PRNEWSWIRE
    15 Sep 2022
    Share Share
    Genentech partnered Novome lands $43.5M to push gastrointestinal drug
    Genentech partnered Novome lands $43.5M to push gastrointestinal drug

    14 Sep 2022

    // Paul Schloesser ENPTS

    https://endpts.com/genentech-partnered-novome-lands-43-5m-from-investor-group/

    Paul Schloesser ENPTS
    14 Sep 2022
    Share Share
    Novome Biotechnologies Raises $43.5 Million Series B Financing
    Novome Biotechnologies Raises $43.5 Million Series B Financing

    13 Sep 2022

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2022/09/13/2514955/0/en/Novome-Biotechnologies-Raises-43-5-Million-Series-B-Financing-to-Advance-its-Pipeline-of-Therapeutically-Engineered-Microbes.html

    GLOBENEWSWIRE
    13 Sep 2022
    Share Share
    Novome Biotechnologies Reports Positive Results from a Phase 1 Study of NOV-001
    Novome Biotechnologies Reports Positive Results from a Phase 1 Study of NOV-001

    17 Nov 2021

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2021/11/17/2336494/0/en/Novome-Biotechnologies-Reports-Positive-Results-from-a-Phase-1-Study-of-NOV-001.html

    GLOBENEWSWIRE
    17 Nov 2021
    Share Share
    Novome Biotechnologies and Genentech Enter into a Strategic Collaboration
    Novome Biotechnologies and Genentech Enter into a Strategic Collaboration

    10 Nov 2021

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2021/11/10/2331578/0/en/Novome-Biotechnologies-and-Genentech-Enter-into-a-Strategic-Collaboration-to-Develop-Targets-Against-Inflammatory-Bowel-Disease.html

    GLOBENEWSWIRE
    10 Nov 2021
    Share Share
    Genentech teams with little Novome on IBD research
    Genentech teams with little Novome on IBD research

    10 Nov 2021

    // John Carroll ENDPTS

    https://endpts.com/genentech-teams-with-little-novome-on-ibd-research-looking-to-colonized-bacteria-after-a-severe-setback/

    John Carroll ENDPTS
    10 Nov 2021
    Share Share

    REF. STANDARDS & IMPURITIES

    Upload your portfolio for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search